Windtree Therapeutics Inc (WINT)
3.571
-0.07
(-1.90%)
USD |
NASDAQ |
May 31, 16:00
3.57
0.00 (0.00%)
After-Hours: 20:00
Windtree Therapeutics Free Cash Flow: -13.86M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -13.86M |
| December 31, 2023 | -13.45M |
| September 30, 2023 | -13.26M |
| June 30, 2023 | -13.50M |
| March 31, 2023 | -15.27M |
| December 31, 2022 | -19.46M |
| September 30, 2022 | -21.19M |
| June 30, 2022 | -22.48M |
| March 31, 2022 | -24.61M |
| December 31, 2021 | -23.94M |
| September 30, 2021 | -23.64M |
| June 30, 2021 | -26.53M |
| March 31, 2021 | -26.17M |
| December 31, 2020 | -25.61M |
| September 30, 2020 | -26.32M |
| June 30, 2020 | -21.78M |
| March 31, 2020 | -21.50M |
| December 31, 2019 | -24.85M |
| September 30, 2019 | -25.52M |
| June 30, 2019 | -25.08M |
| March 31, 2019 | -22.07M |
| December 31, 2018 | -15.78M |
| September 30, 2018 | -14.40M |
| June 30, 2018 | -14.50M |
| March 31, 2018 | -16.26M |
| Date | Value |
|---|---|
| December 31, 2017 | -21.07M |
| September 30, 2017 | 43.88M |
| June 30, 2017 | 38.88M |
| March 31, 2017 | 35.28M |
| December 31, 2016 | 33.31M |
| September 30, 2016 | -34.43M |
| June 30, 2016 | -33.58M |
| March 31, 2016 | -34.18M |
| December 31, 2015 | -33.96M |
| September 30, 2015 | -36.55M |
| June 30, 2015 | -39.65M |
| March 31, 2015 | -40.28M |
| December 31, 2014 | -41.95M |
| September 30, 2014 | -42.20M |
| June 30, 2014 | -41.64M |
| March 31, 2014 | -41.48M |
| December 31, 2013 | -41.06M |
| September 30, 2013 | -39.73M |
| June 30, 2013 | -39.60M |
| March 31, 2013 | -38.19M |
| December 31, 2012 | -33.52M |
| September 30, 2012 | -29.96M |
| June 30, 2012 | -26.12M |
| March 31, 2012 | -23.39M |
| December 31, 2011 | -22.80M |
Free Cash Flow Range, Past 5 Years
-26.53M
Minimum
Jun 2021
-13.26M
Maximum
Sep 2023
-21.40M
Average
-23.06M
Median
Free Cash Flow Benchmarks
| Lexicon Pharmaceuticals Inc | -185.41M |
| AIM ImmunoTech Inc | -23.04M |
| Perspective Therapeutics Inc | -23.28M |
| Protalix BioTherapeutics Inc | 4.369M |
| Armata Pharmaceuticals Inc | -46.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.947M |
| Cash from Financing (Quarterly) | 1.034M |
| Free Cash Flow Per Share (Quarterly) | -6.338 |
| Free Cash Flow Yield | -1.22K% |